BioPharm International, May 2010 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, May 2010
Features
Building Partnerships Between Academia and Biosciences Companies
By Vincent Turula, PhD , Navdeep Malkar, PhD , Richard E. Kouri, PhD
This practicum combines business elements with scientific concepts.
Designing in Quality: Approaches to Defining the Design Space for a Monoclonal Antibody Process
By Amit Banerjee
How to use risk assessment strategies to integrate operations.
Applying Computational Fluid Dynamics Technology in Bioprocesses-Part 2
By Zhiwu (David) Fang
Computational fluid dynamics can resolve performance problems.
Regulatory Beat
Healthcare Reform Expands Coverage, Promotes Innovation
By Jill Wechsler
Broader benefits and biosimilars will offset hefty fees and discounts while preserving R&D incentives.
From the Editor
Pandemic Response: Progress and Challenges
By Laura Bush
We all know that experience is the best teacher. With H1N1, we have a great opportunity to learn important lessons.
Perspectives on Outsourcing
Managing CMOs with Complementary Capabilities
By Roman Hlodan
Formulation strategy is an important consideration when selecting and managing outsourced biopharmaceutical development programs.
Final Word
Are You Ready for a Post-Reform World?
By Jill E. Sackman, PhD , Rita E. Numerof, PhD
The industry must be prepared for the impact of the sweeping changes expected from the new legislation.

ADVERTISEMENT

ADVERTISEMENT

Click here